These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Quantitative determination of cholestanol in plasma with mass fragmentography. Biochemical diagnosis of cerebrotendinous xanthomatosis. Seyama Y, Ichikawa K, Yamakawa T. J Biochem; 1976 Aug; 80(2):223-8. PubMed ID: 794060 [Abstract] [Full Text] [Related]
7. [Cerebrotendinous xanthomatosis]. Berginer VM. Zh Nevropatol Psikhiatr Im S S Korsakova; 1992 Aug; 92(4):13-22. PubMed ID: 1333699 [Abstract] [Full Text] [Related]
8. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis. Salen G, Shefer S, Tint GS. Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073 [Abstract] [Full Text] [Related]
16. Biosynthesis of cholesterol, lanosterol, and delta 7-cholestenol, but not cholestanol, in cultured fibroblasts from normal individuals and patients with cerebrotendinous xanthomatosis. Tint GS, Salen G. J Lipid Res; 1982 May; 23(4):597-603. PubMed ID: 7097124 [Abstract] [Full Text] [Related]
17. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography. Wolthers BG, Volmer M, van der Molen J, Koopman BJ, de Jager AE, Waterreus RJ. Clin Chim Acta; 1983 Jun 30; 131(1-2):53-65. PubMed ID: 6883710 [Abstract] [Full Text] [Related]